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Abstract
Background and Aims: The innate immune cells can not normally respond to the pathogen in patients with
decompensated cirrhosis. Previous studies reported that antigen-presenting cells take up L-Cystine (L-Cys) and secrete
substantial amounts of L-Glutamate (L-Glu) via the transport system Xc- (4F2hc+xCT), and that this exchange influences the
immune responses. The aim of this study is to investigate the influence of the plasma L-Cys/L-Glu imbalance observed in
patients with advanced cirrhosis on the function of circulating monocytes.
Methods: We used a serum-free culture medium consistent with the average concentrations of plasma amino acids from
patients with advanced cirrhosis (ACM), and examined the function of CD14+ monocytes or THP-1 under ACM that
contained 0–300 nmol/mL L-Cys with LPS. In patients with advanced cirrhosis, we actually determined the TNF-alpha and
xCT mRNA of monocytes, and evaluated the correlation between the plasma L-Cys/L-Glu ratio and TNF-alpha.
Results: The addition of L-Cys significantly increased the production of TNF alpha from monocytes under ACM. Monocytes
with LPS and THP-1 expressed xCT and a high level of extracellular L-Cys enhanced L-Cys/L-Glu antiport, and the intracellular
GSH/GSSG ratio was decreased. The L-Cys transport was inhibited by excess L-Glu. In patients with advanced cirrhosis
(n=19), the TNF-alpha and xCT mRNA of monocytes were increased according to the Child-Pugh grade. The TNF-alpha
mRNA of monocytes was significantly higher in the high L-Cys/L-Glu ratio group than in the low ratio group, and the plasma
TNF-alpha was significantly correlated with the L-Cys/L-Glu ratio.
Conclusions: A plasma L-Cys/L-Glu imbalance, which appears in patients with advanced cirrhosis, increased the TNF-alpha
from circulating monocytes via increasing the intracellular oxidative stress. These results may reflect the immune
abnormality that appears in patients with decompensated cirrhosis.
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Introduction
Circulating levels of proinflammatory cytokines such as TNF-
alpha, IL-1 beta and IL-6 are increased in patients with cirrhosis
[1,2,3]. Endotoxemia has been assumed to be responsible for the
increased of such cytokines in patients with cirrhosis [4], because
the activation of monocytes, macrophages and dendritc cells (DCs)
by lipopolysaccharide (LPS) plays a key role in the pathogenesis of
cytokine overproduction. This overproduction of proinflammatory
cytokines leads to various complications, such as spontaneous
bacterial peritonitis (SBP) and hepatorenal syndrome (HRS) in
patients with advanced cirrhosis [5,6].
On the other hand, various types of amino acid imbalance
appear in the plasma of patients with decompensated cirrhosis,
since the liver plays a major role in metabolism involving glucose,
lipids, vitamins,minerals and amino acids. An imbalance of plasma
amino acids, with decreased levels of branched-chain amino acids
(BCAAs) and increased levels of aromatic amino acids (AAAs), is
commonly seen in patients with advanced cirrhosis [7]. Previously,
we reported that extracellular branched-chain amino acids
(BCAAs) regulate the maturation and function of monocyte
derived dendritic cells [8], and that the addition of branched chain
amino acids enhances the maturation and function of myeloid
dendritic cells ex vivo in patients with advanced cirrhosis [9].
However, it is not clear whether the imbalance of amino acids
other than BCAAs influence the immune responses in patients
with advanced cirrhosis. A previous study showed that the
concentration of plasma L- Cystine (L-Cys) is higher in patients
with cirrhosis and shows a wide range of variation [10]. In-
creased levels of L-Glutamine (L-Gln) and decreasing levels of
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23402L-Glutamate (L-Glu) are seen in patients with advanced cirrhosis,
because the L-Glu-L-Gln exchange regulates the high levels of
toxic ammonia in such patients [11]. Furthermore, previous
studies demonstrated that antigen-presenting cells take up L-Cys
via the Na-independent anionic amino acid transport system
Xc
2(4F2hc+xCT) and secrete substantial amounts of L-Glu,
influencing the immune-responses through this exchange
[12,13,14]. This transporter is composed of two protein compo-
nents, xCT and 4F2hc (CD98), and the transport activity is
thought to be mediated by xCT [15,16]. The aim of this study is to
investigate the influence of the extracellular L-Cys/L-Glu
imbalance observed in patients with advanced cirrhosis on the
function of peripheral monocytes using a serum-free culture
medium with the average concentration of plasma amino acids
from patients with advanced cirrhosis [9], thereby approximating
the actual environment of the living body.
Materials and Methods
Ethics Statement
Written informed consent was obtained from each individual
and the study protocol was approved by the Ethics Committee of
Tohoku University School of Medicine (2009-209, 2009-535).
Monocyte count and isolation
In patients with cirrhosis, the monocyte and lymphocyte counts
were measured by a Beckman Coulter LH 750 Analyzer
(Fullerton, CA, USA). PBMCs were separated from the peripheral
blood of healthy volunteers or patients with cirrhosis by
centrifugation on a density gradient. The CD14-positive mono-
cytes were isolated from PBMCs using magnetic microbeads
(Miltenyi Biotec, Bergish Gladbach).
The serum free culture media used in this study
A serum free culture medium with the average concentration of
plasma amino acids from healthy volunteers (HCM), that from
patients with advanced cirrhosis (ACM) and complete culture
media (CCM) were described previously [9]. Other components
except amino acids were identical among media. Various
concentrations of L-Cys were added to L-Cys free ACM , and
the final concentration was adjusted to 0–300 nmol/mL (Table
S1). We cultured CD14+monocytes, THP-1, Jurkat and Molt-4
under the these media with stimulant and measured the amino
acid concentrations of these media. The viability of monocytes and
PBMCs was determined using Annexin V
FITC, with dead cells
identified by propidium iodide (PI) staining (Annexin V
2FITC
Apoptosis Detection Kit, BioVision, Mountain View, CA),
according to the manufacturer’s instructions. We confirmed the
viability of PBMCs cultured in ACM and ACM plus L-Cys to be
equal to that of complete culture medium (CCM) and X-VIVO 10
(Cambrex Bio Science Walkersville, Inc. Walkersville, MD USA).
Patients and Healthy volunteers
The concentrations of the plasma amino acids from fasting
patients with chronic hepatitis (n=17), and patients with cir-
rhosis (n=130) were measured by high-performance liquid
Figure 1. The counts of peripheral monocyte were increased in association with plasma L-Cystine in patients with advanced
cirrhosis. A, B, The concentrations of plasma L-Cys in patients with cirrhosis was increased and that of plasma L-Glu was decreased acccording to
Child-Pugh grade. The levels of plasma L-Cys and L-Glu in patients with cirrrhosis (n=130) were measured using HPLC and classfied by the Child-
Pugh classfication. C, Nonliner regression model was used to model variation in plasma L-Cys and eGFR. D, E,F, Linear regression model was used to
model variation in plasma L-Cys and monocyte and lymphocyte counts. Individual correlations between plasma L-Cys levels and monocyte counts in
patients with early cirrhosis (D), that in patients with advanced cirrhosis (E), and lymphocyte counts in patients with advanced cirrhosis (F). A,B,
**, p,0.01, _*, p,0.05 vs Child-Pugh grade A. Statistical significance was determined by one-way ANOVA and Dunnett’s post-hoc procedure. C, D, E,
F, R
2 represents coefficient of determination.
doi:10.1371/journal.pone.0023402.g001
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licylic acid was added to the plasma to a final concentration of 5%.
The samples were then placed on ice for 15 minutes followed by
centrifugation to remove precipitated proteins. The extracts were
then analyzed for the amino acid content with a JLC-500/V
(Japan Electron Optics Laboratories, Tokyo, Japan). Also, the
patients with cirrhosis were classified according to the Child-Pugh
classification. We defined as Child-Pugh grade B or C the patients
with advanced cirrhosis. The estimated glomerular filtration rate
(eGFR) was calculated using the new Japanese equation [17].
We selected nineteen patients with cirrhosis for in vitro or ex
vivo studies (Table S2). All of these patients were inpatients. The
MELD score [18] was calculated by an on-line worksheet avail-
able on the internet at www.mayoclinic.org/meld/mayomodel5.
html.
Monocyte proliferation assay
Monocytes were cultured at a density of 2.5610
5 cells/well in 96-
well plates containing each media with 1,000 U/mL M-CSF
(PEPROTECH EC, London, UK). One half the amount of culture
fluid was exchanged every one day. Cells were maintained for 20
days and the proliferation rate of the cells was measured using
Carboxyfluorescein Succinimidyl Ester (CFSE) staining; CellTrace
CFSE Cell Proliferation Kit (Molecular Probes, Oregon). The
staining methods followed the manufacturer’s protocol.
Cytokine analysis
PBMCs or monocytes were preincubated at a density of 2.5610
5
cells/well in 96-well flat-bottom plates (CORNING, NY) for
2 hours in each of the media, and 100 ng/mL LPS (Escherichia
coli 026:B6 (SIGMA) were added. The supernatants were collected
after 24 hours and immediately TNF-alpha, IFN-gamma, IL-10,
GM-CSF were determined by specific cytokine ELISA kits (Bender
MedSystems) according to the manufacturer’s instructions.
Surface marker analysis
Monocytes were harvested and labeled with FITC-, PE- and
APC-labeled monoclonal antibodies (mAbs) (anti-human CD14,
CD80, CD86, CD98, HLA-DR, or the relevant isotype controls:
BD PharMingen, San Diego, CA), according to the manufactur-
er’s instructions. On xCT expression, indirect staining was
performed; primary antibody (xCT (H-121) scc-98552: Santa
Cruz) secondary antibody (goat anti-rabbit IgG-FITC sc-2012:
Santa Cruz) Using a FACS Canto II (BD Immunocytometry
Systems, San Diego, CA) flow cytometer, surface marker
expressions were analyzed using the BD FACSDiva (BD
Immunocytometry Systems) program.
Intra-extracellular amino acid quantification
The THP-1, Jurkat and Molt4 cells were pre-incubated for
2 hr in ACM, then 1.0610
7 cells were re-suspended with LPS
(100 ng/mL) or IL-2 (1000 IU/mL) in 1 mL of ACM, L-Cys-free
ACM or ACM with L-Cys. After 2 hr incubation, the
supernatants were measured by HPLC for the extracellular
amino acid quantification. The concentration of the intracellular
amino acids was determined as described in ref [19]. Briefly, cells
were washed two times by PBS and resuspended in 500 mLP B S
sonicated with four 10-s pulses. Cell debris was removed by
centrifugation, and sulfosalicylic acid was added to the superna-
tant to a final concentration of 2%. The samples were then
placed on ice for 30 min followed by centrifugation to remove
precipitated proteins. The extracts were then analyzed for amino
acid content with an L-8500 amino acid analyzer (Hitachi Ltd.,
Tokyo).
Measurement of reduced glutathione (GSH) and oxidized
glutathione (GSSG)
CD14+ monocytes were pre incubated at a density of 2.0610
5
cells/well in 96-well plates containing HCM for 2 h and then
cultured in HCM, ACM or ACM plus L-Cys for an additional
2 h. The culture medium was carefully removed from the wells.
100 ml of prepared GSH-Glo
TM Reagent were added to each well
of a 96-well plate, mixed briefly on a plate shaker, and incubated
at room temperature for 30 minutes. 100 ml of reconstituted
Luciferin Detection Reagent were added to each well of a 96-well
plate, mixed briefly on a plate shaker, and incubated for
15 minutes. luminescence was read by a Lumino Skan Ascent
(Thermo BioAnalysis, Helsinki, Finland).
Real-time PCR
THP-1, Jurkat, Molt-4 and CD14+ monocytes were collected.
After the extraction of total RNA and the RT procedure, real-time
PCR using aTaqMan Chemistry System () was carried out. The
ready-made sets of primers and probes for the amplification of
xCT (Assay ID : Hs00921937_m1), TNF-alpha (Assay ID :
Hs99999043_m1) and glyceraldehyde-3-phosphate-dehydroge-
nase (GAPDH, Assay ID : Hs02758991_g1) were purchased from
Perkin-Elmer/Applied Biosystems. The relative amount of target
mRNA was obtained by using a comparative threshold cycle (CT)
method. The expression level of mRNAs of the Molt-4 was
represented as 1.0 and the relative amounts of target mRNA in
THP-1 and Jurkat were calculated according to the manufactur-
er’s protocol. For CD14+ monocytes, The expression level of
monocyte mRNA from a healthy volunteer was represented as 1.0
and the relative amounts of target mRNA in monocytes from
patients were calculated.
Statistical Analysis
The data were analyzed with ANOVA, and multiple compar-
isons were performed with Dunnett’s post-hoc procedure for the
plasma aminogram. When 2 groups were analyzed, the differences
between media were analyzed by the Wilcoxon t test, and the
Figure 2. L-Cystine dose-dependently increased TNF-alpha from CD14+ monocytes with LPS under the amino acid environment of
patients with advanced cirrhosis. A, Isolated CD14+ monocytes (purity .90%) were cultured at a density of 2.5610
5 cells/well in 96-well plates
containing in ACM and ACM plus L-Cys (L-Cys : 150 nmol/mL) with 1,000 U/mL M-CSF. One half the amount of culture fluid was exchanged every one day.
Cells were maintained for 20daysand the proliferation rate of the cells was measured usingCFSE staining. B, InfluenceofL-Cyson microscopic appearance
of monocyte proliferation under serum-free conditions. Day 20, cells in firmly adherent clusters in both ACM and ACM+Cys. C, Monocytes were cultured
underCCM,HCM,ACM andACM plus L-Cys(100–300 nmol/mL). Cells werepre-incubatedat adensity of 2.5610
5 cells/wellin 96-wellflat-bottomplatesfor
2 hours in each of the media, and 100 ng/mL LPS was added. The supernatants were collected after 24 hours and immediately TNF-alphawas determined
byspecific cytokine ELISA kits. D,E, Similarly as in Fig. 2C, IL-10, IFN gamma from monocytes and GM-CSFfromPBMCs under CCM, HCM, ACM, ACM+Cys (L-
Cys150 nmol/mL)were measured withELISA. F, Cells were harvested after 24 hours, stained with different mAbs, and analyzed using flow cytometry.Cells
werestainedwithFITC-labeledanti-CD14, -CD80,-CD86, and-HLA-DR.A, BandF resultsare representative offourexperiments fromthree different donors.
C, D and E, Mean 6 SEM values from five different donors are shown. C,D,E *, p,0.05 vs ACM (paired Student’s t test, two-tailed).
doi:10.1371/journal.pone.0023402.g002
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by the Mann-Whitney U-test. All statistical analyses were
performed with standard statistical software (SPSS 13.0 for
Windows, Chicago, IL).
Results
The counts of peripheral monocytes were increased in
association with the plasma L-Cystine in patients with
advanced cirrhosis
Firstly, we confirmed that, in patients with advanced cirrhosis
(Child-Pugh grade B or C), the plasma concentrations of L-Cys were
significantly higher than in those with early cirrhosis (Figure 1A), and
there was a wide range of variation. On the other hand, the plasma
concentrations of L-Glu were significantly decreased along with the
Child-Pugh grade (Figure 1B). In patients with advanced cirrhosis,
the wide range of variation of L-Cys was attributed to the eGFR
(R
2=0.28/P=0.0000008) (Figure 1C).These data mean that plasma
L-Cys increases in decompensated cirrhosis. Secondly, we investigate
whether the concentration of plasma L-Cys influenced the peripheral
monocyte counts. In patients with early cirrhosis, L-Cys was not
correlated with the monocyte counts (R
2=0.05/P=0.119)
(Figure 1D), but in patients with advanced cirrhosis, it was
significantly and positively correlated with the monocyte counts
(R
2=0.25/P=0.0000017) (Figure 1E). On the other hand, the
lymphocyte counts were not correlated with the concentration of
plasmaL-Cys(R
2=0.01/P=0.523) (Figure 1F).Interestingly, among
all twenty kinds of free amino acids, only L-Cys was significantly
correlated with the monocyte counts in patients with advanced
cirrhosis (Figure S1). These data mean that, in patients with advanced
cirrhosis, plasma L-Cys is increased according to renal dysfunction
and influences the counts of monocytes.
Extracellular L-Cystine dose-dependently increased pro-inflam-
matory cytokines from CD14+ monocytes under the amino acid
condition of advanced cirrhosis
Based on the result that the peripheral monocyte counts were
positively correlated with the concentration of L-Cys, we hypoth-
esized that the concentration of extracellular L-Cys could influence
the proliferation of monocytes. To investigate this hypothesis, we
cultured monocytes for 20 days with M-CSF under ACM or ACM
plus L-Cys in vitro, and determined the proliferation of monocytes
by CFSE assay. An elevated concentration of L-Cys did not
influence the proliferation of monocytes (Figure 2A) on microscopic
appearance, and also did not affect the morphological appearance
and behavior of the cells in culture (Figure 2B). There was also no
difference in the proliferation of the monocyte cell line, THP-1
between these media (data not shown). Next, to investigate whether
the extracellular L-Cys level influenced the production of
inflammatory cytokines from monocytes, we cultured monocytes
under ACM that contained 50–300 nmol/mL L-Cys and measured
the producton of TNF alpha from monocytes. The addition of L-
Cys increased the production of TNF alpha from monocytes in a
dose-dependent manner (Figure2C),andthe valuesweremaximum
under 150 nmol/mL L-Cys. Interestingly, this range was in
remarkable agreement with the range in patients with advanced
cirrhosis (Fig. 1A). The IL-10 level from monocytes was also
significantly higher under ACM plus L-Cys than that under ACM
(Figure 2D), and there was no difference the interferon gamma (IFN
c) level from monocytes between these media. The GM-CSF from
PBMCs was also significantly higher under ACM plus L-Cys than
that under ACM (Figure 2E). Regarding monocyte phenotypes,
there was no difference between ACM and ACM plus L-Cys
(Figure 2F). These data mean that high levels of extracellular L-Cys
increased pro-inflammatory cytokines from CD14+ monocytes
under the amino acid environment of patients with advanced
cirrhosis.
High levels of extracellular L-Cystine promoted the L-
Cystine-L-Glutamate antiport and decreased the
intracellular GSH/GSSG ratio in monocyte under the
amino acid environment of patients with advanced
cirrhosis
We investigated whether high levels of extracellular L-Cys
influence the L-Cys/L-Glu transport under the amino acid
environment of patients with advanced cirrhosis.
Firstly, we determined the expression of 4F2hc (CD98) and xCT
in THP-1, Jurkat and Molt-4. All cell lines expressed CD98, but
only THP-1 expressed xCT at the protein level (Fig. 3A) and
mRNA level (Fig. 3B). Secondly, we measured the intra-
extracellular L-Cys and L-Glu concentration of THP-1 under
ACM at various L-Cys levels. After 2 hours culture, ACM plus L-
Cys significantly decreased the extracellular L-Cys (mean change,
ACM+Cys, 296.8615.8; ACM, 232.360.6 and ACM dep L-Cys,
4.866.6 nmol/mL) (Fig. 3C) and significantly increased intracellu-
lar L-Cys (Fig. 3D) and extracellular L-Glu (mean change,
ACM+Cys, 157.5619; ACM, 86.1617.7 and ACM dep L-Cys,
40.4624.9 nmol/mL) (Fig. 3C) more than that by ACM or ACM
deprived of L-Cys. For intracellular L-Glu, there was no difference
among these media. Such L-Cys/L-Glu changes were not seen for
Jurkat and Molt-4 (data not shown). These data indicate that high
levels of extracellular L-Cys enhances L-Cys/L-Glu antiport in the
monocyte cell line THP-1. Similarly, CD14+ monocytes expressed
CD98 and xCT after adding LPS (Fig. 3E) and extracellular L-Cys/
L-Glu changes were seen (L-Cys mean change, ACM+Cys,
246.965.0; ACM, 222.466.0; ACM+Cys+Glu, 222.966.4 and
Figure 3. High levels of extracellular L-Cystine promoted the L-Cystine-L-Glutamate antiport via xCT and decreased the
intracellular GSH/GSSG ratio in monocyte under the amino acid environment of patients with advanced cirrhosis. A, THP-1, Jurkat
and Molt-4 cultured under CCM were harvested and labeled with antibodies (CD98, xCT or the relevant isotype controls). Using flow cytometry,
surface marker expressions were analyzed. The figure expresses the mean fluorescence intensity. Data shown are representative of three independent
experiments with cells. B, xCT relative mRNA levels of these cell lines were determined by real time PCR: delta-delta CT method. All mRNA expression
levels were normalized to GAPDH. C, D, The THP-1 cells were pre-incubated for 2 hours in ACM, then resusupended with LPS (100 ng/mL) in 1 mL of
ACM, L-Cys-free ACM and ACM plus L-Cys. The concentration of extracellular (C) and intracellular (D) amino acid was determined as described in
material and methods. E, The CD14+ monocytes, cultured under ACM and ACM plus L-Cys for 24 hours, were harvested and labeled with antibodies
(CD98, xCT or the relevant isotype controls). Using flow cytometry, surface marker expressions were analyzed. The figure expresses the mean
fluorescence Intensity. Data shown are representative of three independent experiments with cells. F, Similarly as in Fig. 4C, the monocytes were
cultured for 24 hours in ACM, L-Cys-free ACM and ACM plus L-Cys. The supernatants were measured by HPLC as extracellular amino acids
quantification. G, Monocytes were pre incubated at a density of 2.0610
5 cells/well in 96-well flat-bottom plates for 2 hours in HCM, and then cultured
in HCM, ACM and ACM plus L-Cys (200 nmol/mL) for an additional 2 hours. These intracellular glutathione levels were measured by GSH-Glo
TM at the
time point indicated. C and D, Mean 6 SD values from five independent experiments are shown. B *, p,0.05 vs Molt-4 (the Mann-Whitney U-test.).
C,F **, p,0.01 *,P,0.05 (mean change vs ACM) D *, p,0.05 (paired Student’s t test, two-tailed).
doi:10.1371/journal.pone.0023402.g003
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ACM+Cys, 70.4624.8; ACM, 25.2613.8 and PBMC-CD14,
10.767.0 nmol/mL) (Fig. 3F). Furthermore, we investigated
whether high levels of extracellular L-Cys influence the intracellular
glutathione level of monocytes. Interestingly, the intracellular GSH
and GSH/GSSG ratio decreased more under ACM plus L-Cys
than under ACM or HCM (Fig. 3G).
Plasma L-Cys/L-Glu ratio significantly correlated with
plasma TNF-alpha level in patients with advanced
cirrhosis
Finally, we actually measured the levels of TNF-alpha of
patients with advanced cirrhosis in monocytes and plasma (Table
S2). In patients with advanced cirrhosis (Table S2: patients 1–19),
the TNF-alpha mRNA expression of monocytes was significantly
Figure 4. The plasma L-Cys/L-Glu ratio significantly correlated with the plasma TNF-alpha level in patients with advanced cirrhosis.
A, CD14+monocytes were isolated from healthy volunteers (n=5) and patients with adcanced cirrhosis (Table S2 : Patient 1–19). the TNF-alpha
relative mRNA levels of CD14+monocytes were determined by real time PCR : delta-delta CT method. All mRNA expression levels were normalized to
GAPDH. B, Similarly as in Fig. 4A, the xCT relative mRNA levels of monocytes were determined by real time PCR. C, These patients were separated into
a high L-Cys/L-Glu ratio group ($1) and low ratio group (,1). In healthy control (HC), the average plasma L-Cys/L-Glu ratio was 0.6160.21. D, Linear
regression model was used to model variation in plasma L-Cys/L-Glu ratio and plasma TNF-alpha. R
2 represents coefficient of determination. E, The
schematic diagram of the present study concerning monocytes abnormality in patients with decompensated cirrhosis. A,B,C *, p,0.05 vs HC (the
Mann-Whitney U-test.).
doi:10.1371/journal.pone.0023402.g004
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expressions also was increased according to the Child-pugh
grade (Fig. 4B). Interestingly, the TNF-alpha mRNA of
monocytes was significantly higher in the high plasma L-Cys/
L-Glu ratio group ($1) than in the low group (,1) (Fig. 4C).
Consistent with these data, the plasma TNF-alpha in the
patients was significantly correlated with the plasma L-Cys/L-
Glu ratio (p=0.0018/r=0.52247) (Fig. 4D). We represented
the schematic diagram of the present study concerning
monocytes abnormality in patients with decompensated cirrhosis
(Fig. 4E).
Discussion
Bacterial infections, such as spontaneous bacterial peritonitis
(SBP) or pneumonia, are frequent clinical complications and
causes of death in patients with advanced cirrhosis [20], because
in such immune-compromised patients the innate immune cells
can not normally respond to the pathogen [21]. Neutrophils,
macrophages, and DCs are important cellular mediators of the
innate immune defense. Circulating monocytes, however, are
increasingly implicated as essential players in the defense against
a range of microbial pathogens [22]. Previously, we made two
serum-free media (HCM and ACM) to examine more closely the
actual amino acid environment of the living body plasma [9].
First, we showed that plasma L-Cys was increased by renal
dysfunction, which is an important factor of the MELD score
[18], and showed a significantly positive correlation with the
monocyte counts in patient with advanced cirrhosis. However,
high levels of L-Cys did not directly influence the proliferation of
monocytes in vitro. This paradox raises the possibility that the
GM-CSF from PBMCs (Fig. 2E) may indirectly increase the
peripheral monocyte counts, because the increase is almost
entirely due to the release from bone marrow [23]. This issue
should be evaluated in future studies. Second, we showed that
extracellular L-Cys dose-dependently increases pro-inflammatory
cytokines from monocytes with LPS under the amino acid
environment of patients with advanced cirrhosis. Concerning the
mechanism that underlies these phenomena, we confirmed that
high extracellular levels of L-Cys enhanced the exchange L-Cys/
L-Glu antiport of monocytes via xCT, and decreased the
intracellular GSH/GSSG ratio under the amino acid condition
of advanced cirrhosis. A previous study showed that oxidized Eh
L-Cysteine/L-Cys induces the upregulation of nuclear factor-
kappa B of monocytes in vitro [24]. These studies support our
results. However, the same studies reported that the oxidized
extracellular Cys/CySS redox state had no effect on cellular
GSH/GSSG redox [24,25]. We think that such differences were
probably caused by differences in the culture condition and
stimulation period of the immune cells, and that our culture
conditions more closely matched the actual amino acid
environment of patients with advanced cirrhosis. However, we
need to investigate in detail by separate quantification of the
reduced form, L-Cysteine; the oxidized form, L-Cys; and the
mixed protein L-Cysteine disulfide. Furthermore, we think that a
low level of plasma L-Glu enhances the antiport in patients with
advanced cirrhosis, because another study reported on a L-Cys
transport system whose activity was inhibited by L-Glu in
mammalian cultured cells [26].
Finally, we confirmed that the TNF-alpha mRNA of CD14
monocytes, isolated from patients with advanced cirrhosis, was at a
higher level than in healthy controls. Furthermore, the value of
plasma TNF-alpha showed a significantly positive correlating with
the plasma L-Cys/L-Glu ratio.
This present results still cannot be construed as conclusive
evidence of a change in the immune system in patients with
advanced cirrhosis. We need to investigate whether L-Cys/L-Glu
imbalance influences other immune cells such as macrophages,
dendritic cells, T-cells and B-cells, and their interaction, and
whether the level of L-Glu influences the immune system, because
previous studies reported that glutamate is a immunomediator in
the intercellular cross-talk between DC and T cells [12,14,27]. In
conclusion, we demonstrated for the first time that an L-Cys/L-
Glu imbalance, especially high levels of L-Cys, increases pro-
inflammatory cytokines, especially TNF-alpha from peripheral
CD14+ monocytes under the amino acid condition of advanced
cirrhosis in vitro, and these results are consistent with the
relationships among plasma L-Cys and TNF-alpha in patients
with advanced cirrhosis. This study may provide a new approach
for future studies to ameliorate the immune dysfunction in patients
with advanced cirrhosis.
Supporting Information
Figure S1 Linear regression model was used to model variation
in plasma L-Cys and monocyte count. Among all twenty kinds of
free amino acids, only L-Cys was significantly correlated with the
monocyte counts in patients with advanced cirrhosis.
(TIF)
Table S1 The serum free culture media used in this study.
‘ACM (advanced cirrhotic medium) consistent with the average
concentration of plasma amino acids from patients (Child-Pugh
grade B or C, n=90). ACM+Cys: Varying concentrations of L-
Cys were added to L-Cys-free ACM, and the final concentration
was adjusted to 100–300 nmol/mL. ACM dep Cys: L-Cys free
ACM. Other components except amino acids, were identical
among media. The amino acid concentrations are expressed in
nmol/mL. Fischer’s ratio=(Valine+Leucine+Isoleucine)/(Tyrosi-
ne+Phenylalanine). We verified that there was no difference
between the theoretical value and actual value examined by high
performance liquid chromatography.
(DOC)
Table S2 Characteristics of study participants. LC-C: liver
cirrhosis due to HCV LC-B: liver cirrhosis due to HBV HCC:
hepatocellular carcinoma PBC: Primary biliary cirrhosis Alco-
holic: Alcoholic cirrhosis NASH: non alcoholic steatohepatitis
HA: Hepatic Encephalopathy PLT: platelet counts (610
3/mL)
PT-INR: prothrombin time-international normalized ratio
AST/ALT: aspartate amino transferase/alanine amino transfer-
ase (IU/L) Total Bilirubin (mg/dL) Albumin (g/dL) Fischer’s
ratio mean: L-Valine+L-Leucine+L-Isoleucine/L-Tyrosine+L-
Phenylalanine.
(DOC)
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